Insights from 2024 WCLC
Videos
Insights from 2024 WCLC
WCLC 2024 Insights: Health-Related QoL Outcomes With Adagrasib vs. Docetaxel in KRASG12C-Mutated aNSCLC - KRYSTAL-12
FEATURING
Robert Jotte
- 21 views
- October 28, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Therapy Debate in NSCLC
FEATURING
Jan Von Der Thusen
- 282 views
- October 21, 2024
- 6
Insights from 2024 WCLC
WCLC 2024 Insights: KRAS G12C Inhibitor IBI351 in Advanced NSCLC
FEATURING
Qing Zhou
- 25 views
- October 17, 2024
Insights from 2024 WCLC
WCLC 2024 Summary: Genomic Landscape of SCLC and Its Evolution
FEATURING
Julie George
- 45 views
- October 14, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Risk-Adapted and Response-Adapted Strategies for Stage 3 NSCLC
FEATURING
Andrea Filippi
- 33 views
- October 11, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: The Global TRUST-II Study - Efficacy & Safety of Taletrectinib in Patients With ROS1+ NSCLC
FEATURING
Geoffrey Liu
- 38 views
- October 11, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Augmented Imaging Techniques for Peripheral Nodules
FEATURING
Carrie Leong
- 291 views
- October 2, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: Addition of Cytotoxic Chemotherapy to Targeted Therapy in NSCLC
FEATURING
Bruna Pellini
- 163 views
- October 1, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Mitigating Chemoradiation Toxicity in LA-NSCLC
FEATURING
Dawn Owen
- 18 views
- October 1, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Management of Radiation Toxicities in The Era of Chemo-Immunotherapy
FEATURING
Percy Lee
- 101 views
- September 24, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Analysis of Lung Cancer-Specific Patient-Reported Outcome Measures - Results From the PRO4All Project
FEATURING
Alberto Servetto
- 25 views
- September 23, 2024
Insights from 2024 WCLC
WCLC 2024 Summary: Comparing Treatment for Locally Advanced NSCLC - Debate Overview
FEATURING
Jessica Donington
- 164 views
- September 23, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion
FEATURING
Pyng Lee
- 2,055 views
- September 23, 2024
- 12
Insights from 2024 WCLC
WCLC 2024 Insights: Interstitial Lung Disease and Lung Cancer - How Should We Proceed
FEATURING
Satoshi Ikeda
- 388 views
- September 23, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: The Impact of Air Pollution on Lung Cancer in Developing Countries
FEATURING
Upal Basu Roy
- 35 views
- September 23, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Therapy for NSCLC - Rational Targeted Combinations
FEATURING
Melina Marmarelis
- 113 views
- September 23, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Long-Term Follow Up on Pembro + Itacitinib in PD-L1 Positive Metastatic NSCLC
FEATURING
Melina Marmarelis
- 22 views
- September 23, 2024
Insights from 2024 WCLC
FLAURA2 Trial: Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemo in EGFR-Mutated Advanced NSCLC
FEATURING
Natalia Valdivieso
- 187 views
- September 23, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: PACIFIC-BRAZIL Study - Intensified Chemo-Immuno-Radiotherapy With Durvalumab for Stage III NSCLC
FEATURING
William William
- 42 views
- September 23, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: MARIPOSA - Amivantamab + Lazertinib vs. Osimertinib in 1L EGFR-Mut Advanced NSCLC
FEATURING
Shirish Gadgeel
- 413 views
- September 20, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Summary: Minimally Invasive Monitoring of Immunotherapy Response via ctDNA Approaches in NSCLC
FEATURING
Valsamo Anagnostou
- 69 views
- September 20, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Summary: Treatment Considerations for SCLC Patients With Pre-Existing Interstitial Lung Disease
FEATURING
Daichi Fujimoto
- 162 views
- September 20, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Highlights of Coming Advances in mNSCLC - Cytotoxics, IO, and KRAS Inhibitors
FEATURING
Brian Henick
- 122 views
- September 19, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Cemiplimab Monotherapy in PD-L1 ≥50% Advanced NSCLC - 5-Year EMPOWER-Lung 1 Results
FEATURING
Ana Baramidze
- 53 views
- September 19, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Occupational Exposure and Lung Cancer
FEATURING
Paul Demers
- 22 views
- September 19, 2024
Insights from 2024 WCLC
WCLC 2024 Insights: Biology of CNS Metastases in NSCLC
FEATURING
Timothy Burns
- 160 views
- September 19, 2024
- 3
Insights from 2024 WCLC
WCLC 2024 Insights: Effect of De Novo Co-Mutations on Clinical Outcomes in Patients Receiving 1L Osimertinib for EGFRm mNSCLC
FEATURING
Fangdi Sun
- 30 views
- September 18, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: LAURA Study - Osimertinib After Definitive CRT in Unresectable Stage III EGFRm NSCLC
FEATURING
Terufumi Kato
- 101 views
- September 18, 2024
Insights from 2024 WCLC
WCLC 2024 Summary: Survival Outcomes and Pathologic Response After Chemoimmunotherapy in Resectable NSCLC
FEATURING
Daniele Marinelli
- 57 views
- September 18, 2024
- 2
Insights from 2024 WCLC
WCLC 2024 Insights: Management of Brain Metastases in Oncogene-Driven NSCLC - Timing, Sequency, and Modality of RT
FEATURING
Joe Chang
- 131 views
- September 18, 2024